Opioids: The role in headache pharmacotherapy

Rob Hutchison, PharmD

doi:10.5055/jom.2005.0041

Authors

Rob Hutchison, PharmD

DOI:

https://doi.org/10.5055/jom.2005.0041

Keywords:

-

Abstract

-

Author Biography

Rob Hutchison, PharmD

Clinical pharmacy specialist in pain management at Presbyterian Hospital of Dallas and assistant professor at Texas Tech University Health Sciences Center School of Pharmacy, in Dallas, Texas. Author email: robhutchison@texashealth.org.

References

Katsarava Z, Schneeweiss S, Kurth T, et al.: Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology. 2004; 62: 788-790.

Bahra A, Walsh M, Menon S, et al.: Does chronic daily headache arise de novo in association with regular use of analgesics? Headache. 2003; 43: 179-190.

Katsarava Z, Limmroth V, Finke M, et al.: Rates and predictors for relapse in medication overuse headache: A 1-year prospective study. Neurology. 2003; 60: 1682-1683.

Matchar DB, Young WB, Rosenerg J, et al.: Multispecialty consensus on diagnosis and treatment of headache: Pharmacological management of acute attacks. Available online at: http://www.aan.com/professionals/practice/pdfs/gl0087.pdf. Last accessed June 13, 2005.

Headache Classification Committee of the International Headache Society: The International Classification of Headache Disorders. Cephalalgia. 2004; 24: 1-160.

Saper JR, Lake AE, Hamel RL, et al.: Daily scheduled opioids for intractable head pain: Long-term observations of a treatment program. Neurology. 2004; 62: 1687-1694.